Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Controversies in the management of hepatocellular carcinoma.

Forner A, Da Fonseca LG, Díaz-González Á, Sanduzzi-Zamparelli M, Reig M, Bruix J.

JHEP Rep. 2019 Mar 18;1(1):17-29. doi: 10.1016/j.jhepr.2019.02.003. eCollection 2019 May. Review.

2.

Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients.

Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A.

J Vasc Interv Radiol. 2019 Nov 1. pii: S1051-0443(19)30576-7. doi: 10.1016/j.jvir.2019.06.014. [Epub ahead of print]

PMID:
31685360
3.

Liver International: Anticipating the future of hepatology worldwide.

Valenti L, Aghemo A, Forner A.

Liver Int. 2019 Oct;39(10):1796-1797. doi: 10.1111/liv.14240. No abstract available.

PMID:
31553529
4.

Radiological Incidence of Unilateral Pulmonary Edema After Minimally Invasive Cardiac Surgery.

Khalil NH, Anders R, Forner AF, Gutberlet M, Ender J.

J Cardiothorac Vasc Anesth. 2020 Jan;34(1):151-156. doi: 10.1053/j.jvca.2019.07.006. Epub 2019 Jul 7.

PMID:
31405722
5.

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Rimola J, Forner A, Sapena V, Llarch N, Darnell A, Díaz A, García-Criado A, Bianchi L, Vilana R, Díaz-González Á, Ayuso C, Bruix J, Reig M.

Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1.

PMID:
31372783
6.

Advantages of Damage Control Strategy With Abdominal Negative Pressure and Instillation in Patients With Diffuse Peritonitis From Perforated Diverticular Disease.

Brillantino A, Andreano M, Lanza M, D'Ambrosio V, Fusco F, Antropoli M, Lucia A, Zito ES, Forner A, Ambrosino F, Monte G, Cricrì AM, Robustelli U, De Masi A, Calce R, Ciardiello G, Renzi A, Castriconi M.

Surg Innov. 2019 Dec;26(6):656-661. doi: 10.1177/1553350619857561. Epub 2019 Jun 21.

PMID:
31221028
7.

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.

Ayuso C, Forner A, Darnell A, Rimola J, García-Criado Á, Bianchi L, Vilana R, Oliveira R, Llarch N, Bruix J.

Liver Int. 2019 Jul;39(7):1281-1291. doi: 10.1111/liv.14133. Epub 2019 May 28.

PMID:
31077539
8.

Systemic doxorubicin and hepatocellular carcinoma: the end of an era never risen up.

Sanduzzi-Zamparelli M, Forner A.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):418-420. doi: 10.1016/S2468-1253(19)30091-3. Epub 2019 Apr 4. No abstract available.

PMID:
30954566
9.

Clinical presentation, diagnosis and staging of cholangiocarcinoma.

Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvisé M, Lamarca A.

Liver Int. 2019 May;39 Suppl 1:98-107. doi: 10.1111/liv.14086. Epub 2019 Mar 25. Review.

PMID:
30831002
10.

Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib.

Díaz-González Á, Sanduzzi-Zamparelli M, Sapena V, Torres F, LLarch N, Iserte G, Forner A, da Fonseca L, Ríos J, Bruix J, Reig M.

Aliment Pharmacol Ther. 2019 Mar;49(5):482-491. doi: 10.1111/apt.15088. Epub 2019 Jan 29.

PMID:
30695819
11.

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.

de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, de Bernardo N, AlarcÓn J, Fuente C, Carrera S, Sancho D, GarcÍa-Pardo P, Pascual R, JuÁrez M, Cuerda-Ballester M, Forner A, Sancho-Castillo S, Barrios C, Obrador E, Marchio P, Salvador R, Holmes HE, Dellinger RW, Guarente L, Estrela JM.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):115-122. doi: 10.1080/21678421.2018.1536152. Epub 2019 Jan 22.

PMID:
30668199
12.

Carbon-ion radiotherapy for HCC-A potential tool to fulfil an unmet gap in the treatment algorithms?

Da Fonseca LG, Forner A.

Liver Int. 2018 Dec;38(12):2132-2133. doi: 10.1111/liv.13990. No abstract available.

PMID:
30480378
13.

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.

Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T.

Cancer Treat Rev. 2019 Jan;72:28-36. doi: 10.1016/j.ctrv.2018.11.002. Epub 2018 Nov 12. Review.

PMID:
30447470
14.

Prognosis assessment by pathologist: Is the detection of intratumoural tertiary lymphoid structures a reliable tool?

Díaz A, Forner A.

J Hepatol. 2019 Jan;70(1):11-12. doi: 10.1016/j.jhep.2018.10.017. Epub 2018 Nov 7. No abstract available.

PMID:
30414735
15.

A rare cause of systemic inflammatory response syndrome.

Caballol B, Ruiz P, Ferrer-Fàbrega J, Diaz A, Forner A.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):383-384. doi: 10.1016/j.gastrohep.2018.07.003. Epub 2018 Aug 9. English, Spanish. No abstract available.

PMID:
30100208
16.

Transcatheter treatment of tricuspid regurgitation using edge-to-edge repair: procedural results, clinical implications and predictors of success.

Lurz P, Besler C, Noack T, Forner AF, Bevilacqua C, Seeburger J, Rommel KP, Blazek S, Hartung P, Zimmer M, Mohr F, Schuler G, Linke A, Ender J, Thiele H.

EuroIntervention. 2018 Jun 8;14(3):e290-e297. doi: 10.4244/EIJ-D-17-01091.

17.

Extreme droughts affecting Mediterranean tree species' growth and water-use efficiency: the importance of timing.

Forner A, Valladares F, Bonal D, Granier A, Grossiord C, Aranda I.

Tree Physiol. 2018 Aug 1;38(8):1127-1137. doi: 10.1093/treephys/tpy022.

PMID:
29554342
18.

Hepatocellular carcinoma.

Forner A, Reig M, Bruix J.

Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5. Review.

PMID:
29307467
19.

Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.

Agüero F, Forner A, Valdivieso A, Blanes M, Barcena R, Manzardo C, Rafecas A, Castells L, Abradelo M, Barrera-Baena P, González-Diéguez L, Salcedo M, Serrano T, Jiménez-Pérez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Liver Transpl. 2017 May;23(5):645-651. doi: 10.1002/lt.24741.

20.

Surveillance for hepatocellular carcinoma.

Díaz-González Á, Forner A.

Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):1001-1010. doi: 10.1016/j.bpg.2016.10.006. Epub 2016 Oct 21. Review.

PMID:
27938779
21.

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.

Londoño MC, Manzardo C, Rimola A, Ruiz P, Costa J, Forner A, Ambrosioni J, Agüero F, Laguno M, Lligoña A, Moreno A, Miró JM.

J Antimicrob Chemother. 2016 Nov;71(11):3195-3201. Epub 2016 Jul 7.

PMID:
27402009
22.

Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet.

Forner A, Rimola J, Ayuso C.

J Hepatol. 2016 Sep;65(3):648-9. doi: 10.1016/j.jhep.2016.05.047. Epub 2016 Jun 14. No abstract available.

PMID:
27312943
23.

[Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH].

Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J.

Med Clin (Barc). 2016 Jun 3;146(11):511.e1-511.e22. doi: 10.1016/j.medcli.2016.01.028. Epub 2016 Mar 11. Spanish.

PMID:
26971984
24.

New challenges in clinical research on hepatocellular carcinoma.

Díaz-González Á, Forner A, Rodríguez de Lope C, Varela M.

Rev Esp Enferm Dig. 2016 Aug;108(8):485-93. doi: 10.17235/reed.2015.4012/2015. Review.

25.

Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.

Ferrer-Fàbrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M, Fondevila C, García-Valdecasas JC, Bruix J, Fuster J.

Hepatology. 2016 Mar;63(3):839-49. doi: 10.1002/hep.28339. Epub 2016 Jan 13.

PMID:
26567038
26.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
27.

Does ramucirumab deserve a second chance for liver cancer?

Forner A, Reig M.

Lancet Oncol. 2015 Jul;16(7):751-2. doi: 10.1016/S1470-2045(15)00053-4. Epub 2015 Jun 18. No abstract available.

PMID:
26095780
28.

Hepatocellular carcinoma surveillance with miRNAs.

Forner A.

Lancet Oncol. 2015 Jul;16(7):743-5. doi: 10.1016/S1470-2045(15)00014-5. Epub 2015 Jun 15. No abstract available.

PMID:
26088271
29.

Intermediate-stage HCC--upfront resection can be feasible.

Forner A, Gilabert M, Bruix J, Raoul JL.

Nat Rev Clin Oncol. 2015 May;12(5). doi: 10.1038/nrclinonc.2014.122-c4. Epub 2015 Apr 7. No abstract available.

PMID:
25850552
30.

Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.

Forner A, Vilana R, Solé M, Bruix J.

J Hepatol. 2015 Jun;62(6):1453-4. doi: 10.1016/j.jhep.2015.02.016. Epub 2015 Feb 19. No abstract available.

31.

Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.

Darnell A, Forner A, Rimola J, Reig M, García-Criado Á, Ayuso C, Bruix J.

Radiology. 2015 Jun;275(3):698-707. doi: 10.1148/radiol.15141132. Epub 2015 Feb 5.

PMID:
25658038
32.

Reply: Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.

Forner A, Gilabert M, Bruix J, Raoul JL.

Nat Rev Clin Oncol. 2015 Jan;12(1):10. doi: 10.1038/nrclinonc.2014.122-c2. Epub 2014 Nov 25. No abstract available.

PMID:
25421282
33.

Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

Reig M, Darnell A, Forner A, Rimola J, Ayuso C, Bruix J.

Semin Liver Dis. 2014 Nov;34(4):444-55. doi: 10.1055/s-0034-1394143. Epub 2014 Nov 4. Review.

PMID:
25369306
34.

Prognosis prediction and staging.

Forner A, Díaz-González A, Liccioni A, Vilana R.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):855-65. doi: 10.1016/j.bpg.2014.08.002. Epub 2014 Aug 23. Review.

PMID:
25260313
35.

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

Forner A, Vilana R, Bianchi L, Rodríguez-Lope C, Reig M, García-Criado MÁ, Rimola J, Solé M, Ayuso C, Bru C, Bruix J.

J Hepatol. 2015 Jan;62(1):150-5. doi: 10.1016/j.jhep.2014.08.028. Epub 2014 Aug 27.

PMID:
25173969
36.

Treatment of intermediate-stage hepatocellular carcinoma.

Forner A, Gilabert M, Bruix J, Raoul JL.

Nat Rev Clin Oncol. 2014 Sep;11(9):525-35. doi: 10.1038/nrclinonc.2014.122. Epub 2014 Aug 5. Review.

PMID:
25091611
37.

[Ablative techniques and the clinical utility of ablation as first-line treatment in the initial phase of hepatocellular cancer].

Forner A.

Gastroenterol Hepatol. 2014 Jul;37 Suppl 2:90-4. doi: 10.1016/S0210-5705(14)70075-5. Spanish.

PMID:
25087718
38.

Acute symptomatic Meckel diverticulum management. Our experience on seven consecutive cases.

Robustelli U, Manguso F, Armellino MF, Mannelli MP, Massa MR, Forner AL, Bellotti R, Ambrosino F, Severino BU.

Ann Ital Chir. 2014 Mar-Apr;85(2):129-35.

PMID:
24901680
39.

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.

Reig M, Torres F, Rodriguez-Lope C, Forner A, LLarch N, Rimola J, Darnell A, Ríos J, Ayuso C, Bruix J.

J Hepatol. 2014 Aug;61(2):318-24. doi: 10.1016/j.jhep.2014.03.030. Epub 2014 Apr 2.

PMID:
24703956
40.

[Are alpha-fetoprotein and other markers useful in the diagnosis and prognosis of hepatocellular carcinoma?].

Forner A, Liccioni A, Reig ME.

Gastroenterol Hepatol. 2014 Jan;37(1):17-20. doi: 10.1016/j.gastrohep.2013.09.006. Epub 2013 Dec 11. Review. Spanish. No abstract available.

PMID:
24332662
41.

Contrasting water strategies of two Mediterranean shrubs of limited distribution: uncertain future under a drier climate.

Lázaro-Nogal A, Forner A, Traveset A, Valladares F.

Tree Physiol. 2013 Dec;33(12):1284-95. doi: 10.1093/treephys/tpt103. Epub 2013 Dec 5.

PMID:
24319030
42.

The size of the problem: clinical algorithms.

Forner A, Bruix J.

Dig Dis. 2013;31(1):95-103. doi: 10.1159/000347201. Epub 2013 Jun 17. Review.

PMID:
23797130
43.

Consensus report of the Fifth International Forum for Liver MRI.

Zech CJ, Bartolozzi C, Bioulac-Sage P, Chow PK, Forner A, Grazioli L, Huppertz A, Laumonier H, Min Lee J, Murakami T, Ricke J, Sirlin CB.

AJR Am J Roentgenol. 2013 Jul;201(1):97-107. doi: 10.2214/AJR.12.9491.

PMID:
23789662
44.

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.

Reig M, Rimola J, Torres F, Darnell A, Rodriguez-Lope C, Forner A, Llarch N, Ríos J, Ayuso C, Bruix J.

Hepatology. 2013 Dec;58(6):2023-31. doi: 10.1002/hep.26586. Epub 2013 Oct 29.

PMID:
23787822
45.

Natural history and staging for hepatocellular carcinoma.

Forner A, Rodríguez-Lopez C, Reig M.

Clin Liver Dis (Hoboken). 2013 Jan 23;1(6):183-185. doi: 10.1002/cld.129. eCollection 2012 Dec. Review. No abstract available.

46.

[Contrast-enhanced ultrasonography in the diagnosis of hepatocellular carcinoma].

Forner A, Bruix J.

Radiologia. 2013 Mar-Apr;55(2):173-4. doi: 10.1016/j.rx.2012.10.002. Epub 2012 Dec 8. Spanish. No abstract available.

47.

Approach of the patient with a liver mass.

Rodríguez de Lope C, Reig ME, Darnell A, Forner A.

Frontline Gastroenterol. 2012 Oct;3(4):252-262. doi: 10.1136/flgastro-2012-100146. Epub 2012 Aug 11. Review.

48.

Biomarkers for early diagnosis of hepatocellular carcinoma.

Forner A, Bruix J.

Lancet Oncol. 2012 Aug;13(8):750-1. doi: 10.1016/S1470-2045(12)70271-1. Epub 2012 Jun 26. No abstract available.

PMID:
22738800
49.

Hepatocellular carcinoma.

Forner A, Llovet JM, Bruix J.

Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20. Review.

PMID:
22353262
50.

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, Ayuso C, Llovet JM, Real MI, Bruix J.

J Hepatol. 2012 Jun;56(6):1330-5. doi: 10.1016/j.jhep.2012.01.008. Epub 2012 Feb 5.

PMID:
22314428

Supplemental Content

Loading ...
Support Center